35 results
Page 2 of 2
8-K
EX-99.1
i87249cw85
7 Jan 19
Presentation to Lorem Ipsum Dolor May 2018 Corporate Presentation January 2019
8:54am
424B3
3v0xoq972141nc82
20 Dec 18
Prospectus supplement
4:19pm
8-K
EX-99.1
7ki37hd
13 Dec 18
Millendo Therapeutics Announces Successful Merger Completion
4:08pm
DEFM14A
jjrfb06zsg1fqjvf4r
6 Nov 18
Proxy related to merger
12:00am
424B3
ra4475qwhsrra96bc
5 Nov 18
Prospectus supplement
3:51pm
S-4/A
fftsdff5
1 Nov 18
Registration of securities issued in business combination transactions (amended)
5:32pm
8-K
EX-99.1
efpxjg
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
8-K
EX-99.2
zyp bhd119h5f
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
8-K
EX-99.3
w1ibvcjcagzs7vl3p
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
425
EX-99.3
3sfui17p
9 Aug 18
Business combination disclosure
5:17pm
425
EX-99.2
uccl7dh83qhhzb9 k4i
9 Aug 18
Business combination disclosure
5:17pm
425
EX-99.1
w8i3ujm 64ezpxj2gk4
9 Aug 18
Business combination disclosure
5:17pm